Thus, after studying an appropriate dose of SDC to intervene T2DM, future study may focus on the gut microbiota-bile acid-liver axis, tight junctions, FXR and TGR5 expression levels of intestine and liver tissues in depth to connect the gut microbial changes with metabolic and gut health. The gene discussed is NR1H4; the disease is type 2 diabetes mellitus.